738 related articles for article (PubMed ID: 7562472)
1. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
2. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
[TBL] [Abstract][Full Text] [Related]
3. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
[TBL] [Abstract][Full Text] [Related]
4. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
[TBL] [Abstract][Full Text] [Related]
5. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
Lazareno S; Dolezal V; Popham A; Birdsall NJ
Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
[TBL] [Abstract][Full Text] [Related]
6. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
7. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
Ehlert FJ; Oliff HS; Griffin MT
J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
[TBL] [Abstract][Full Text] [Related]
8. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
Proska J; Tucek S
Mol Pharmacol; 1994 Apr; 45(4):709-17. PubMed ID: 8183250
[TBL] [Abstract][Full Text] [Related]
10. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
11. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
Ellis J; Huyler J; Brann MR
Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
[TBL] [Abstract][Full Text] [Related]
12. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
Buckley NJ; Bonner TI; Buckley CM; Brann MR
Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
[TBL] [Abstract][Full Text] [Related]
13. Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells.
Dong GZ; Kameyama K; Rinken A; Haga T
J Pharmacol Exp Ther; 1995 Jul; 274(1):378-84. PubMed ID: 7616422
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
Musílková J; Tucek S
Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
[TBL] [Abstract][Full Text] [Related]
15. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies.
Birdsall NJ; Farries T; Gharagozloo P; Kobayashi S; Lazareno S; Sugimoto M
Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037
[TBL] [Abstract][Full Text] [Related]
16. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
17. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1991 Feb; 256(2):468-79. PubMed ID: 1993991
[TBL] [Abstract][Full Text] [Related]
18. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
19. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
20. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]